some moderately attractive bits of news today.....
REGN, SIBI, TGEN..... comments, nominations, etc. welcome. Volume
is currently a raging zero for SIBI, so nobody agrees with me.
Best news from yesterday, IMO, was also from SIBI.... but,
preclinical in this case is nowhere near getting over our hurdle. The
CEGE nomination failed to get past the "random integration" question?
In the event that SUGN gets carried away by 60 minutes fever, suggest
looking at OSIP as an obvious sympathy play? CELG and REGN too?
03/25/99 VRTX, 3-D structure of ribavirin bound to IMPDH
03/10/99 MLNM, clones mahogany, obesity target or lab curiosity?
03/09/99 VRTX, initiates phase I trial with p38 MAP kinase inhibitor
03/08/99 CNTO, sales force leverage, LMW heparin with PNU
03/04/99 AGPH, describes crystal structure for VEGFR2 kinase
03/02/99 INCY, using new chemistry from Amersham Pharmacia, flying
03/01/99 GLIA, finishes single-dose portion of phase I, GT-2331
03/01/99 GILD, NXTR merger
02/26/99 MEDI/Ixsys, MAb alliance, including anti-alpha-v beta-3
02/25/99 ONXX, Bayer select lead compound, ras pathway inhibitor |
